APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Paclitaxel Injection

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

Selected research

Industry Growth & Trends

Global Paclitaxel Injection Industry Growth and Trends Forecast to 2032

Report ID 174021720120 December 2025109 pages

Choose your research edition.

Industry ResearchPaclitaxel Injection Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Paclitaxel Injection Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Paclitaxel Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paclitaxel Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Paclitaxel Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers.

Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks.

Global Paclitaxel Injection key players include Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E., Luye Pharma, etc. Global top five players hold a share about 80%.

Read the full market overview

Europe is the largest market, with a share about 25%, followed by North America and China, having a total share about 40 percent.

In terms of product, 5ml,30mg is the largest segment, with a share about 75%. And in terms of application, the largest application is Ovarian Cancer, followed by Breast Cancer, Cervical Cancer, Pancreatic Cancer.

Report Scope

This report provides a structured, data-driven view of the global Paclitaxel Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Paclitaxel Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Paclitaxel Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Paclitaxel Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Paclitaxel Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Paclitaxel Injection Market by Company

Bristol-Myers Squibb

Celgene Corporation

Hospira

Biological E.

Taj Accura

Khandelwal Laboratories

Luye Pharma

Beijing Youcare

Beijing Union

Haiyao

Chuntch

Paclitaxel Injection Segment by Type

5ml,30mg

10ml,60mg

16.7ml,100mg

25ml,150mg

50ml,300mg

Paclitaxel Injection Segment by Application

Ovarian Cancer

Breast Cancer

Cervical Cancer

Pancreatic Cancer

Other

Paclitaxel Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paclitaxel Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paclitaxel Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paclitaxel Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paclitaxel Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Paclitaxel Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5ml,30mg Table 2. Major Company of 10ml,60mg Table 3. Major Company of 16.7ml,100mg Table 4. Major Company of 25ml,150mg Table 5. Major Company of 50ml,300mg Table 6. Global Paclitaxel Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Paclitaxel Injection Sales by Type (2021-2026) & (K Units) Table 8. Global Paclitaxel Injection Sales Market Share in Volume by Type (2021-2026) Table 9. Global Paclitaxel Injection Sales by Type (2021-2026) & (US$ Million) Table 10. Global Paclitaxel Injection Sales Market Share in Value by Type (2021-2026) Table 11. Global Paclitaxel Injection Price by Type (2021-2026) & (USD/Unit) Table 12. Global Paclitaxel Injection Sales by Type (2027-2032) & (K Units) Table 13. Global Paclitaxel Injection Sales Market Share in Volume by Type (2027-2032) Table 14. Global Paclitaxel Injection Sales by Type (2027-2032) & (US$ Million) Table 15. Global Paclitaxel Injection Sales Market Share in Value by Type (2027-2032) Table 16. Global Paclitaxel Injection Price by Type (2027-2032) & (USD/Unit) Table 17. North America Paclitaxel Injection Sales by Type (2021-2026) & (K Units) Table 18. North America Paclitaxel Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Paclitaxel Injection Sales by Type (2021-2026) & (K Units) Table 20. Europe Paclitaxel Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Paclitaxel Injection Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Paclitaxel Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Paclitaxel Injection Sales by Type (2021-2026) & (K Units) Table 24. Latin America Paclitaxel Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Paclitaxel Injection Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Paclitaxel Injection Sales by Type (2021-2026) & (US$ Million) Table 27. Paclitaxel Injection Industry Trends Table 28. Paclitaxel Injection Industry Drivers Table 29. Paclitaxel Injection Industry Opportunities and Challenges Table 30. Paclitaxel Injection Industry Restraints Table 31. Global Paclitaxel Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Paclitaxel Injection Revenue Market Share by Company (2021-2026) Table 33. Global Paclitaxel Injection Sales by Company (2021-2026) & (K Units) Table 34. Global Paclitaxel Injection Sales Share by Company (2021-2026) Table 35. Global Paclitaxel Injection Market Price by Company (2021-2026) & (USD/Unit) Table 36. Global Paclitaxel Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Paclitaxel Injection Major Company Production Sites and Headquarters Table 38. Global Paclitaxel Injection Company, Product Type & Application Table 39. Global Paclitaxel Injection Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Paclitaxel Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Paclitaxel Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Paclitaxel Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Paclitaxel Injection Sales Market Share in Volume by Region (2021-2026) Table 45. Global Paclitaxel Injection Sales by Region (2021-2026) & (US$ Million) Table 46. Global Paclitaxel Injection Sales Market Share in Value by Region (2021-2026) Table 47. Global Paclitaxel Injection Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Global Paclitaxel Injection Sales by Region (2027-2032) & (K Units) Table 49. Global Paclitaxel Injection Sales Market Share in Volume by Region (2027-2032) Table 50. Global Paclitaxel Injection Sales by Region (2027-2032) & (US$ Million) Table 51. Global Paclitaxel Injection Sales Market Share in Value by Region (2027-2032) Table 52. Global Paclitaxel Injection Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 53. Global Paclitaxel Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Paclitaxel Injection Sales by Application (2021-2026) & (K Units) Table 55. Global Paclitaxel Injection Sales Market Share in Volume by Application (2021-2026) Table 56. Global Paclitaxel Injection Sales by Application (2021-2026) & (US$ Million) Table 57. Global Paclitaxel Injection Sales Market Share in Value by Application (2021-2026) Table 58. Global Paclitaxel Injection Price by Application (2021-2026) & (USD/Unit) Table 59. Global Paclitaxel Injection Sales by Application (2027-2032) & (K Units) Table 60. Global Paclitaxel Injection Sales Market Share in Volume by Application (2027-2032) Table 61. Global Paclitaxel Injection Sales by Application (2027-2032) & (US$ Million) Table 62. Global Paclitaxel Injection Sales Market Share in Value by Application (2027-2032) Table 63. Global Paclitaxel Injection Price by Application (2027-2032) & (USD/Unit) Table 64. North America Paclitaxel Injection Sales by Application (2021-2026) & (K Units) Table 65. North America Paclitaxel Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Paclitaxel Injection Sales by Application (2021-2026) & (K Units) Table 67. Europe Paclitaxel Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Paclitaxel Injection Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Paclitaxel Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Paclitaxel Injection Sales by Application (2021-2026) & (K Units) Table 71. Latin America Paclitaxel Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Paclitaxel Injection Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Paclitaxel Injection Sales by Application (2021-2026) & (US$ Million) Table 74. Bristol-Myers Squibb Company Information Table 75. Bristol-Myers Squibb Business Overview Table 76. Bristol-Myers Squibb Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Bristol-Myers Squibb Paclitaxel Injection Product Portfolio Table 78. Bristol-Myers Squibb Recent Development Table 79. Celgene Corporation Company Information Table 80. Celgene Corporation Business Overview Table 81. Celgene Corporation Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Celgene Corporation Paclitaxel Injection Product Portfolio Table 83. Celgene Corporation Recent Development Table 84. Hospira Company Information Table 85. Hospira Business Overview Table 86. Hospira Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Hospira Paclitaxel Injection Product Portfolio Table 88. Hospira Recent Development Table 89. Biological E. Company Information Table 90. Biological E. Business Overview Table 91. Biological E. Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Biological E. Paclitaxel Injection Product Portfolio Table 93. Biological E. Recent Development Table 94. Taj Accura Company Information Table 95. Taj Accura Business Overview Table 96. Taj Accura Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Taj Accura Paclitaxel Injection Product Portfolio Table 98. Taj Accura Recent Development Table 99. Khandelwal Laboratories Company Information Table 100. Khandelwal Laboratories Business Overview Table 101. Khandelwal Laboratories Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Khandelwal Laboratories Paclitaxel Injection Product Portfolio Table 103. Khandelwal Laboratories Recent Development Table 104. Luye Pharma Company Information Table 105. Luye Pharma Business Overview Table 106. Luye Pharma Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 107. Luye Pharma Paclitaxel Injection Product Portfolio Table 108. Luye Pharma Recent Development Table 109. Beijing Youcare Company Information Table 110. Beijing Youcare Business Overview Table 111. Beijing Youcare Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 112. Beijing Youcare Paclitaxel Injection Product Portfolio Table 113. Beijing Youcare Recent Development Table 114. Beijing Union Company Information Table 115. Beijing Union Business Overview Table 116. Beijing Union Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 117. Beijing Union Paclitaxel Injection Product Portfolio Table 118. Beijing Union Recent Development Table 119. Haiyao Company Information Table 120. Haiyao Business Overview Table 121. Haiyao Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 122. Haiyao Paclitaxel Injection Product Portfolio Table 123. Haiyao Recent Development Table 124. Chuntch Company Information Table 125. Chuntch Business Overview Table 126. Chuntch Paclitaxel Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 127. Chuntch Paclitaxel Injection Product Portfolio Table 128. Chuntch Recent Development Table 129. North America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. North America Paclitaxel Injection Sales by Country (2021-2026) & (K Units) Table 131. North America Paclitaxel Injection Sales Market Share by Country (2021-2026) Table 132. North America Paclitaxel Injection Sales Forecast by Country (2027-2032) & (K Units) Table 133. North America Paclitaxel Injection Sales Market Share Forecast by Country (2027-2032) Table 134. North America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Paclitaxel Injection Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Paclitaxel Injection Market Share by Country (2021-2026) Table 137. North America Paclitaxel Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Paclitaxel Injection Market Share Forecast by Country (2027-2032) Table 139. Europe Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Europe Paclitaxel Injection Sales by Country (2021-2026) & (K Units) Table 141. Europe Paclitaxel Injection Sales Market Share by Country (2021-2026) Table 142. Europe Paclitaxel Injection Sales Forecast by Country (2027-2032) & (K Units) Table 143. Europe Paclitaxel Injection Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Paclitaxel Injection Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Paclitaxel Injection Market Share by Country (2021-2026) Table 147. Europe Paclitaxel Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Paclitaxel Injection Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Paclitaxel Injection Sales by Country (2021-2026) & (K Units) Table 151. Asia-Pacific Paclitaxel Injection Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Paclitaxel Injection Sales Forecast by Country (2027-2032) & (K Units) Table 153. Asia-Pacific Paclitaxel Injection Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Paclitaxel Injection Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Paclitaxel Injection Market Share by Country (2021-2026) Table 157. Asia-Pacific Paclitaxel Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Paclitaxel Injection Market Share Forecast by Country (2027-2032) Table 159. Latin America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Latin America Paclitaxel Injection Sales by Country (2021-2026) & (K Units) Table 161. Latin America Paclitaxel Injection Sales Market Share by Country (2021-2026) Table 162. Latin America Paclitaxel Injection Sales Forecast by Country (2027-2032) & (K Units) Table 163. Latin America Paclitaxel Injection Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Paclitaxel Injection Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Paclitaxel Injection Market Share by Country (2021-2026) Table 167. Latin America Paclitaxel Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Paclitaxel Injection Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Paclitaxel Injection Sales by Country (2021-2026) & (K Units) Table 171. Middle East and Africa Paclitaxel Injection Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Paclitaxel Injection Sales Forecast by Country (2027-2032) & (K Units) Table 173. Middle East and Africa Paclitaxel Injection Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Paclitaxel Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Paclitaxel Injection Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Paclitaxel Injection Market Share by Country (2021-2026) Table 177. Middle East and Africa Paclitaxel Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Paclitaxel Injection Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Paclitaxel Injection Distributors List Table 182. Paclitaxel Injection Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Paclitaxel Injection Image Figure 2. Global Paclitaxel Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paclitaxel Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Paclitaxel Injection Sales (2021-2032) & (K Units) Figure 5. 5ml,30mg Image Figure 6. Global 5ml,30mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10ml,60mg Image Figure 8. Global 10ml,60mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 16.7ml,100mg Image Figure 10. Global 16.7ml,100mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. 25ml,150mg Image Figure 12. Global 25ml,150mg Sales YoY Growth (2021-2032) & (K Units) Figure 13. 50ml,300mg Image Figure 14. Global 50ml,300mg Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Paclitaxel Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Paclitaxel Injection Market Share by Type 2025 VS 2032 Figure 17. North America Paclitaxel Injection Sales Market Share in Volume by Type in 2025 Figure 18. North America Paclitaxel Injection Sales Market Share in Value by Type in 2025 Figure 19. Europe Paclitaxel Injection Sales Market Share in Volume by Type in 2025 Figure 20. Europe Paclitaxel Injection Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Paclitaxel Injection Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Paclitaxel Injection Sales Market Share in Value by Type in 2025 Figure 23. Latin America Paclitaxel Injection Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Paclitaxel Injection Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Paclitaxel Injection Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Paclitaxel Injection Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Paclitaxel Injection Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Ovarian Cancer Image Figure 30. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Breast Cancer Image Figure 32. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Cervical Cancer Image Figure 34. Global Cervical Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 35. Pancreatic Cancer Image Figure 36. Global Pancreatic Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Paclitaxel Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Paclitaxel Injection Market Share by Application 2025 VS 2032 Figure 41. North America Paclitaxel Injection Sales Market Share in Volume by Application in 2025 Figure 42. North America Paclitaxel Injection Sales Market Share in Value by Application in 2025 Figure 43. Europe Paclitaxel Injection Sales Market Share in Volume by Application in 2025 Figure 44. Europe Paclitaxel Injection Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Paclitaxel Injection Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Paclitaxel Injection Sales Market Share in Value by Application in 2025 Figure 47. Latin America Paclitaxel Injection Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Paclitaxel Injection Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Paclitaxel Injection Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Paclitaxel Injection Sales Market Share in Value by Application in 2025 Figure 51. North America Paclitaxel Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Paclitaxel Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Paclitaxel Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Paclitaxel Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Paclitaxel Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Paclitaxel Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Paclitaxel Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Paclitaxel Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Paclitaxel Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Paclitaxel Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Paclitaxel Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Paclitaxel Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Paclitaxel Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Paclitaxel Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Paclitaxel Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Paclitaxel Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Paclitaxel Injection Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Paclitaxel Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 5ml,30mg
  • 10ml,60mg
  • 16.7ml,100mg
  • 25ml,150mg
  • 50ml,300mg
Applications
  • Ovarian Cancer
  • Breast Cancer
  • Cervical Cancer
  • Pancreatic Cancer
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Hospira
  • Biological E.
  • Taj Accura
  • Khandelwal Laboratories
  • Luye Pharma
  • Beijing Youcare
  • Beijing Union
  • Haiyao
  • Chuntch

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Paclitaxel Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Paclitaxel Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Paclitaxel Injection Market by Type
  6. 1.3.1 5ml,30mg
  7. 1.3.2 10ml,60mg
  8. 1.3.3 16.7ml,100mg
  9. 1.3.4 25ml,150mg
  10. 1.3.5 50ml,300mg
  11. 1.4 Global Paclitaxel Injection Market Size by Type
  12. 1.4.1 Global Paclitaxel Injection Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Paclitaxel Injection Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Paclitaxel Injection Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Paclitaxel Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Paclitaxel Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Paclitaxel Injection Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Paclitaxel Injection Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Paclitaxel Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Paclitaxel Injection Industry Trends
  2. 2.2 Paclitaxel Injection Industry Drivers
  3. 2.3 Paclitaxel Injection Industry Opportunities and Challenges
  4. 2.4 Paclitaxel Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Paclitaxel Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Paclitaxel Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Paclitaxel Injection Price (2021-2026)
  4. 3.4 Global Paclitaxel Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paclitaxel Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Paclitaxel Injection Company, Product Type & Application
  7. 3.7 Global Paclitaxel Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paclitaxel Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paclitaxel Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paclitaxel Injection Tier 1, Tier 2, and Tier 3
4 Paclitaxel Injection Regional Status and Outlook
  1. 4.1 Global Paclitaxel Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Paclitaxel Injection Historic Market Size by Region
  3. 4.2.1 Global Paclitaxel Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Paclitaxel Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Paclitaxel Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Paclitaxel Injection Forecasted Market Size by Region
  7. 4.3.1 Global Paclitaxel Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Paclitaxel Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Paclitaxel Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Paclitaxel Injection by Application
  1. 5.1 Paclitaxel Injection Market by Application
  2. 5.1.1 Ovarian Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Cervical Cancer
  5. 5.1.4 Pancreatic Cancer
  6. 5.1.5 Other
  7. 5.2 Global Paclitaxel Injection Market Size by Application
  8. 5.2.1 Global Paclitaxel Injection Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Paclitaxel Injection Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Paclitaxel Injection Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Paclitaxel Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Paclitaxel Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Paclitaxel Injection Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Paclitaxel Injection Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Paclitaxel Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb
  2. 6.1.1 Bristol-Myers Squibb Company Information
  3. 6.1.2 Bristol-Myers Squibb Business Overview
  4. 6.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Paclitaxel Injection Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Recent Developments
  7. 6.2 Celgene Corporation
  8. 6.2.1 Celgene Corporation Company Information
  9. 6.2.2 Celgene Corporation Business Overview
  10. 6.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Celgene Corporation Paclitaxel Injection Product Portfolio
  12. 6.2.5 Celgene Corporation Recent Developments
  13. 6.3 Hospira
  14. 6.3.1 Hospira Company Information
  15. 6.3.2 Hospira Business Overview
  16. 6.3.3 Hospira Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Hospira Paclitaxel Injection Product Portfolio
  18. 6.3.5 Hospira Recent Developments
  19. 6.4 Biological E.
  20. 6.4.1 Biological E. Company Information
  21. 6.4.2 Biological E. Business Overview
  22. 6.4.3 Biological E. Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biological E. Paclitaxel Injection Product Portfolio
  24. 6.4.5 Biological E. Recent Developments
  25. 6.5 Taj Accura
  26. 6.5.1 Taj Accura Company Information
  27. 6.5.2 Taj Accura Business Overview
  28. 6.5.3 Taj Accura Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taj Accura Paclitaxel Injection Product Portfolio
  30. 6.5.5 Taj Accura Recent Developments
  31. 6.6 Khandelwal Laboratories
  32. 6.6.1 Khandelwal Laboratories Company Information
  33. 6.6.2 Khandelwal Laboratories Business Overview
  34. 6.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Khandelwal Laboratories Paclitaxel Injection Product Portfolio
  36. 6.6.5 Khandelwal Laboratories Recent Developments
  37. 6.7 Luye Pharma
  38. 6.7.1 Luye Pharma Company Information
  39. 6.7.2 Luye Pharma Business Overview
  40. 6.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Luye Pharma Paclitaxel Injection Product Portfolio
  42. 6.7.5 Luye Pharma Recent Developments
  43. 6.8 Beijing Youcare
  44. 6.8.1 Beijing Youcare Company Information
  45. 6.8.2 Beijing Youcare Business Overview
  46. 6.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Beijing Youcare Paclitaxel Injection Product Portfolio
  48. 6.8.5 Beijing Youcare Recent Developments
  49. 6.9 Beijing Union
  50. 6.9.1 Beijing Union Company Information
  51. 6.9.2 Beijing Union Business Overview
  52. 6.9.3 Beijing Union Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Beijing Union Paclitaxel Injection Product Portfolio
  54. 6.9.5 Beijing Union Recent Developments
  55. 6.10 Haiyao
  56. 6.10.1 Haiyao Company Information
  57. 6.10.2 Haiyao Business Overview
  58. 6.10.3 Haiyao Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Haiyao Paclitaxel Injection Product Portfolio
  60. 6.10.5 Haiyao Recent Developments
  61. 6.11 Chuntch
  62. 6.11.1 Chuntch Company Information
  63. 6.11.2 Chuntch Business Overview
  64. 6.11.3 Chuntch Paclitaxel Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Chuntch Paclitaxel Injection Product Portfolio
  66. 6.11.5 Chuntch Recent Developments
7 North America by Country
  1. 7.1 North America Paclitaxel Injection Sales by Country
  2. 7.1.1 North America Paclitaxel Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Paclitaxel Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Paclitaxel Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Paclitaxel Injection Market Size by Country
  6. 7.2.1 North America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Paclitaxel Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Paclitaxel Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Paclitaxel Injection Sales by Country
  2. 8.1.1 Europe Paclitaxel Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Paclitaxel Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Paclitaxel Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Paclitaxel Injection Market Size by Country
  6. 8.2.1 Europe Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Paclitaxel Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Paclitaxel Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Paclitaxel Injection Sales by Country
  2. 9.1.1 Asia-Pacific Paclitaxel Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Paclitaxel Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Paclitaxel Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Paclitaxel Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Paclitaxel Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Paclitaxel Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Paclitaxel Injection Sales by Country
  2. 10.1.1 South America Paclitaxel Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Paclitaxel Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Paclitaxel Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Paclitaxel Injection Market Size by Country
  6. 10.2.1 South America Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Paclitaxel Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Paclitaxel Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Paclitaxel Injection Sales by Country
  2. 11.1.1 Middle East and Africa Paclitaxel Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Paclitaxel Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Paclitaxel Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Paclitaxel Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Paclitaxel Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Paclitaxel Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Paclitaxel Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Paclitaxel Injection Value Chain Analysis
  2. 12.1.1 Paclitaxel Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Paclitaxel Injection Production Mode & Process
  7. 12.2 Paclitaxel Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Paclitaxel Injection Distributors
  10. 12.2.3 Paclitaxel Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst